Filing Flows › Comparisons › BSX vs BAX
Boston Scientific vs Baxter International: BSX and BAX compared
Boston Scientific is the larger company: $5.1B of revenue in its latest quarter (Q3 2026) against $3.0B for Baxter International (Q3 2026). Baxter International is growing faster (+5% against +1% a year earlier). Boston Scientific is more profitable, with an operating margin of 16.1% against 7.6%.
Where the money goes: BSX and BAX
Boston Scientific (BSX) · Q3 2026
Boston Scientific, Q3 2026: revenue $5.1B (+1% year over year), operating margin 16.1%, net earnings $580M, operating cash flow $1.0B. The chart follows the revenue to costs, profit and cash.
Baxter International (BAX) · Q3 2026
Baxter International, Q3 2026: revenue $3.0B (+5% year over year), operating margin 7.6%, net earnings $294M, operating cash flow $558M. The chart follows the revenue to costs, profit and cash.
| Boston Scientific (BSX) | Baxter International (BAX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $5.1B | $3.0B |
| Revenue growth, Y/Y | +1% | +5% |
| Gross margin | 66.7% | 33.4% |
| Operating margin | 16.1% | 7.6% |
| Net earnings | $580M | $294M |
| Net margin | 11.3% | 9.9% |
| Operating cash flow | $1.0B | $558M |
| Free cash flow | $868M | $448M |
| Market value | $64.8B | $13.4B |
| P/E | 18.9× | — |
| Analysts’ mean target | $49.60 | $27.25 |
Where the revenue comes from
Boston Scientific
- Interventional Cardiology & Vascular Therapies: $1.3B (25%)
- Electrophysiology: $816M (16%)
- Endoscopy: $741M (14%)
- Urology: $661M (13%)
Questions
Which is bigger, Boston Scientific or Baxter International?
Boston Scientific is the larger company: $5.1B of revenue in its latest quarter (Q3 2026) against $3.0B for Baxter International (Q3 2026).
Is Boston Scientific or Baxter International growing faster?
Baxter International is growing faster (+5% against +1% a year earlier).
Which is more profitable, Boston Scientific or Baxter International?
Boston Scientific is more profitable, with an operating margin of 16.1% against 7.6%.
More: Boston Scientific earnings · how Boston Scientific makes money · Baxter International earnings · how Baxter International makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 2, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.